Seroprevalence and risk factors of Hepatitis B and C Virus infection Among Inmates in a Correctional Service, Nasarawa State, Nigeria

Mojisola Christiana Owoseni; Bashiru Eya Sani; Hamida Damilare Usman

doi:10.62050/ljsir2024.v2n1.301

Seroprevalence and risk factors of Hepatitis B and C Virus infection Among Inmates in a Correctional Service, Nasarawa State, Nigeria

Authors

Mojisola Christiana Owoseni
moji.owoseni@gmail.com

Department of Microbiology, Federal University of Lafia, PMB 146, Lafia, Nasarawa State, Nigeria
Bashiru Eya Sani
Department of Microbiology, Federal University of Lafia, PMB 146, Lafia, Nasarawa State, Nigeria
Hamida Damilare Usman
Department of Microbiology, Federal University of Lafia, PMB 146, Lafia, Nasarawa State, Nigeria

Keywords:

Array, Array, Array, Array, Array

Abstract

Hepatitis infection has remained a reoccurring public health challenge. The seroprevalence of Hepatitis B and Hepatitis C virus infection among inmates in Lafia correctional service, Nasarawa State, Nigeria was assessed. Blood samples of 120 inmates were screened using the HBV surface antigen (HBsAg) rapid test Dip-strip and HCVAb plus rapid test strip. Socio-demographic and risk factors were analyzed using Fishers exact test binary logistics regression (p ≤ 0.05). Inmates were 29.16 % HBV and 8.3% HCV seropositive. Male inmates were 30% HBV and 8.18% HCV and females were 20% HBV and 10% HCV seropositive. Inmates ≥ 40 years and married inmates are more likely to be infected with HBV and HCV infections. Illicit drug use and incarceration above 5 years were risk factors significant for HBV and HCV prevalence. The high seroprevalence and risk factors of HBV and HCV infections among inmates needs prompt sensitization, screening and vaccination programmes.

Dimensions

REFERENCES

World Health Organization. Global health sector strategy on viral hepatitis 2016–2021 (2016). Towards ending viral hepatitis. World Health Organization. Available on https://apps.who.int/iris/handle/10665/246177. Accessed: 23/03/203.

World Health Organization. Global Hepatitis Report. Geneva: Switzerland. 2017; World Health Organization (WHO). (2017) Available on https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf?sequence=1&isAllowed=y. Accessed: 23/03/2023.

Olayinka A.T., Oyemakinde A., Balogun, M. S., Ajudua A., Nguku, P., Aderinola, M. (2016) Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey. Am J Trop Med Hyg; 95(4), 902–907. https://doi.org/10.4269/ajtmh.15-0874.

World Health Organization. Hepatitis B. 2014. Available at: http://www who.inf/inf-s/ en/fact204.html. Accessed: 23/03/2023.

Gétaz,, L., Casillas, A, Siegrist, C. et al. (2018). Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland’s largest pre-trial prison. J Global Health; 8 (2): 1 -11. https://doi.org/10.7189/jogh.08.020407.

Jafari, S., Buxton, J.A., Afshar, K., Copes, R., Baharlou, S. (2012). Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can J Public Health; 103:207-12. Medline:22905640..

Uchechukwu, O.F., Abdulrahman, Y., Aliyu, A.U., Mustaphar, U., Zama. I., Charles, A.T. (2018). Seroprevalence of HIV, HBsAg and HCV among Prisoners in Sokoto, Nigeria. Asian J Med Health; 13(3): 1-8. ISSN:2456-8414.

Adoga M.P., Banwat, E.B., Forbi, J.C., Nimzing, L., Pam, C.R., Gyar, S.D. (2009). Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: seroprevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Countries; 3(7):539-547.

Dan-Nwafor, C.C. Adeoye, I., Aderemi, K., Onuoha, M., Adedire, E, Bashorun, A. et al. (2021). Serological markers and risk factors associated with Hepatitis B virus infection among Federal Capital Territory prison inmates, Nigeria: Should we be concerned? PloS One 16 (3): e0248045. https://doi.org/10.1371/journal.pone.0248045.

Kassa Y, Million, Y, Biset S, Moges F. (2021). Hepatitis B and Hepatitis C Viral Infections and Associated Factors Among Prisoners in Northeast Ethiopia. J Blood Med; 12: 561–570. https://doi.org/10.2147/JBM.S314556.

Ajuwon B I, Yujuico I, Roper K, Richardson A, Sheel M, L. (2021). Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. BMC Infectious Dis.; 21:1120. https://doi.org/10.1186/s12879-021-06800-6.

Okafor I.M., Ugwu SO and Okoroiwu H U. (2020). Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison. BMC Gastroenterol; 20:360. https://doi.org/10.1186/s12876-020-01504-8.

Musa B.M., Bussell S., Borodo, M.M., Samaila, A.A., Femi, O.L. (2015). Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis. Nig J Clin Pract; 18(2): 163 -172.

Babatope, I.O., Inyang N.J., Imhanrenezor, K, Aghahowa A. (2015). Seroprevalence of Hepatitis B and C viruses among apparently healthy adults in Ekpoma, Edo State, Nigeria. SVPJ 1(1):0015–20.

Luciani, F., Bretaña, N.A., Teutsch, S. et al. (2014). A prospective study of Hepatitis C incidence in Australian prisoners. Addiction; 109: 1695-1706. https://doi.org/10.1111/add.12643.

Gough E, Kempf MC, Graham L, et al. HIV and Hepatitis B and C incidence rates in US correctional populations and high - risk groups: a systematic review and meta-analysis. BMC Public Health 2010; 10:777.

Published

2024-04-23

How to Cite

Seroprevalence and risk factors of Hepatitis B and C Virus infection Among Inmates in a Correctional Service, Nasarawa State, Nigeria. (2024). Lafia Journal of Scientific and Industrial Research, 2(1), 65-69. https://doi.org/10.62050/ljsir2024.v2n1.301